BCL2 and Parkinson disease: This signaling is characterized by increased intrinsic and extrinsic signaling involving Bax/BcL-2 proteins, leading to the loss of NK1 receptors after 40 days of PD induction, which results in breathing dysfunction (Falquetto et al., 2020).